Navigation Links
Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases
Date:5/5/2009

TAMPA, Fla., May 5 /PRNewswire-USNewswire/ -- The Tampa Lions Eye Institute for Transplant and Research, Inc. (LEITR) today announced plans to open a new 12,000-square-foot facility in Tampa, Florida. This state-of-the-art facility will offer high-volume, high-quality human ocular tissue for research, study, collaboration, and clinical advancements, as well as extensive space for on-site residence, sleeping quarters, and meetings/events.

This marks an expansion of the current 35,000 square-foot Tampa Eye Bank facility, already the world's largest eye bank. This new model -- a Research Institute built within an eye bank -- is believed to be the first of its kind in the world.

For more than 30 years, LEITR has provided over 30,000 corneas for transplant and 50,000 eyes for research worldwide. LEITR recognized that research into blinding diseases had to be greatly expanded, particularly due to the exponential growth and incidence of macular degeneration and glaucoma. "The LEITR expansion means that, for the first time, diseased as well as healthy human eye tissue will be available to us for research," says Dr. Henry Edelhauser, Ferst Professor at Emory University Eye Center. "This availability of a full spectrum of human eye tissue will improve our understanding of the underlying events that lead to blindness. Even more importantly, what we learn will eventually have a tremendous, positive impact on quality of life for patients with blinding diseases."

Transforming Ocular Research

Key to the successful advancement of ocular tissue research is having the highest quality human tissue available. Over the years, LEITR recognized that time between tissue donor death and tissue recovery was essential. Current methods of providing tissue, particularly overnight shipping to facilities, has greatly affected the quality of that tissue. Now, researchers will have a repository of high-quality human ocular tissue on site at LEITR.

Racing Against Time

As the U.S. population ages, the prevalence of macular degeneration and glaucoma have affected millions of Americans. Macular degeneration is the leading cause of visual loss in the elderly and the condition profoundly affects their quality of life. Glaucoma, affecting upwards of 3 million Americans, contributes to over 120,000 new cases of blindness each year and is the leading cause of blindness among African Americans. LEITR's initial research platforms will explore the leading causes of these two blinding diseases, providing diseased or compromised eyes for advancing research in these disease areas.

LEITR is also forming a distinguished advisory board, consisting of thought leaders from top academic eye institutions around the country. Collaborative relationships with academic, government, and pharmaceutical industry research centers will be established to facilitate accelerated drug innovation, timely clinical trials, and a foundation for best research practices.

The LEITR Mission

"Our stated mission is to set new standards for ocular research that will improve visual outcomes and quality of life for those who are blind or visually impaired," says Jason K. Woody, Executive Director and CEO of LEITR. "We intend to be the new pioneers of ocular research."

About LEITR

LEITR is a non-profit, charitable organization dedicated to the recovery, evaluation, and distribution of eye tissue for transplantation, research, and education. The eye institute is one of the largest in the world. Since its inception, it has brought the "Gift of Sight" to over 20,000 men, women, and children worldwide. LEITR was founded by a group of Tampa Lions in 1973. Since the beginning, the eye institute has been guided by a board of directors comprised of Lions and prominent ophthalmic specialists and surgeons. For more information call Jason K. Woody at 1-813-289-1200, visit our Web site at www.lionseyeinstitute.org.


'/>"/>
SOURCE Lions Eye Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Kansas Invests Millions in Innovations to Improve Human Health and Launches Three National Bioscience Programs at BIO08
2. Joslin Study Identifies Key Factor That Links Metabolic Syndrome; Finding May Help Millions at High Risk of Cardiovascular Disease
3. Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia
4. Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference
5. Midwest Research Institute Launches Clinical Molecular Diagnostics Laboratory
6. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
7. Research Teams at J. Craig Venter Institute and Ludwig Institute for Cancer Research Uncover New Chromosomal Alterations in Cancer Using Transcriptome Sequencing Approach
8. Roskamp Institute Identifies New Class of Drugs to Treat Alzheimers Disease
9. Open Letter to President-Elect Barack Obama From Don Margolis, Chairman and Founder of The Repair Stem Cell Institute
10. Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
11. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Ill. , Feb. 8, 2016  Astellas Pharma Inc. ... announced the promotion of James Robinson as president, ... company,s operations in North and South America ... Astellas Pharma US, representing the commercial organization in ... in 2013. Masao Yoshida , who is ...
(Date:2/8/2016)... Feb. 8, 2016  CTI BioPharma Corp. (CTI BioPharma) ... written communication from the U.S. Food and Drug Administration ... placed a partial clinical hold on the clinical studies ... application for pacritinib. This clinical hold impacts part of ... and will also affect planned clinical trials. ...
(Date:2/5/2016)... , Feb. 5, 2016  Redwood Scientific Technologies, ... new product designed to help women balance their hormones. ... delivery technology. Jason Cardiff , President ... be able to help the millions of women across ... the effects of imbalanced hormones. Our research and development ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... Eating ... a significant number of women and men with eating disorders report a history ... best predicts the development of an eating disorder. , At the 2016 ...
(Date:2/8/2016)... ... 2016 , ... GrassrootsHealth published data from its D*action public ... in the GrassrootsHealth cohort with substantially higher vitamin D levels than a cohort ... states Carole Baggerly, Director of GrassrootsHealth, “the safety and benefits of vitamin ...
(Date:2/8/2016)... Las Vegas, Nevada (PRWEB) , ... February 08, ... ... Co-Founder at RowdMap, Inc., will be speaking on how healthcare companies can use ... project costs, manage the health of a population and intervene and capture the ...
(Date:2/8/2016)... ... , ... According to research by the National Association of ... be certified or obtain continuing education. To increase patient awareness of the lack ... campaign to inform dentists and patients about the possible lack of skills and ...
(Date:2/7/2016)... (PRWEB) , ... February 07, 2016 , ... ... MyDecision™ program. MyDecision™ empowers employers and organizations with the tools and information to ... combines three elements to cut the cost of providing employee healthcare benefits by ...
Breaking Medicine News(10 mins):